Skip to main content
TipRanks
Go Ultimate75% OFF

Archer completes Biosensor beta prototype

Archer completes Biosensor beta prototype
Image source: Shutterstock

An update from Archer Materials ( (AU:AXE) ) is now available.

Archer Materials is a quantum technology company operating in the semiconductor industry, developing chips and devices for quantum computing, sensing and medical diagnostics. Its Biosensor is focused on point-of-care blood testing, with lithium testing as the initial application and blood potassium among broader diagnostic applications.

The company has completed a beta prototype integrating the cartridge, chip packaging, sensors, reader and readout electronics into a kit supporting the workflow from finger-prick sample to displayed result in six minutes. The device is ready for external testing, validation and initial manufacturing design, while discussions with tier-one clinical partners are progressing to evaluate lithium testing against established laboratory methods.

More about Archer Materials

Archer Materials is a quantum technology company operating in the semiconductor industry, developing advanced devices and chips for quantum computing, sensing and medical diagnostics, with applications across multiple industries.

Average Trading Volume: 364,479

Technical Sentiment Signal: Sell

Current Market Cap: A$48.33M

For a thorough assessment of AXE stock, go to TipRanks’ Stock Analysis page.

This article was AI-generated from the company’s official filing, with automated quality checks and editorial spot-checks.

Disclaimer & DisclosureReport an Issue

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!